From OpenWetWare
Jump to navigationJump to search

Equipped with his five senses, man explores the universe around him and calls the adventure Science. ~Edwin Powell Hubble, The Nature of Science, 1954

Home        Projects        Team        Papers        Contact Us        Protocols        Collaborations        News        Reagent Requests        secret back door        Hoatlin Lab Twitter       

Click here for Hoatlin Lab's PubMed listing

Back to Main Page Hoatlin Lab

  • Note: PDF reprints are provided below within the context of fair use. Please obtain copies from the publisher if appropriate.
  1. A new FAN of the stalled replication fork. Hoatlin ME. Cell Cycle. 2010 Nov;9(21):4261-2. Epub 2010 Nov 1. Online.
  2. A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability. Yan Z, Delannoy M, Ling C, Daee D, Osman F, Muniandy PA, Shen X, Oostra AB, Du H, Steltenpool J, Lin T, Schuster B, Décaillet C, Stasiak A, Stasiak AZ, Stone S, Hoatlin ME, Schindler D, Woodcock CL, Joenje H, Sen R, de Winter JP, Li L, Seidman MM, Whitby MC, Myung K, Constantinou A, Wang W. Mol Cell. 2010 Mar 26;37(6):865-78.Online.
  3. Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors. Igor Landais, Sanne Hiddingh, Matthew McCarroll, Chao Yang, Aiming Sun, Mitchell S Turker, James P Snyder and Maureen E Hoatlin. Molecular Cancer. 2009. Online
  4. SSRP1 facilitates microtubule growth and bundling required for mitosis. Shelya X. Zeng, Yanping Li, Yetao Jin, Qi Zhang, David M. Keller, Carolyn M.McQuaw, Eric Barklis, Stacie Stone, Maureen Hoatlin, Yingming Zhao,and Hua Lu. Mol Cell Biol. 2009. Online
  5. Zhang H, Fraser ST, Papazoglu C, Hoatlin ME, Baron MH. Transcriptional Activation by the Mixl1 Homeodomain Protein in Differentiating Mouse Embryonic Stem Cells. Stem Cells. 2009 Online
  6. Sobeck A, Stone S, Landais I, de Graaf B, Hoatlin ME. The Fanconi anemia protein FANCM is controlled by FANCD2 and the ATR/ATM pathways. J Biol Chem.2009. Sept 18;284(38):25560-8. Epub 2009 Jul 24. Online
  7. Landais I, Sobeck A, Stone S, LaChapelle A, and Hoatlin ME. A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway.Int J Cancer. 2009 Feb 15;124(4):783-92. Online (cover).
  8. Xu, Dongyi, Guo, Rong, Sobeck, Alexandra, Bachrati, Csanad Z., Yang, Jay, Enomoto, Takemi, Brown, Grant W., Hoatlin, Maureen E., Hickson, Ian D., Wang, Weidong. RMI, a new OB-fold complex essential for Bloom syndrome protein to maintain genome stability. Genes Dev. 2008 22: 2843-2855. See Genes and Development Perspective and Nature News & Views.
  9. Wang LC, Stone S, Hoatlin ME, Gautier J. Fanconi anemia proteins stabilize replication forks.DNA Repair. Epub ahead of print, Sep 8, 2008.
  10. JB Wilson, K Yamamoto, AS Marriott, S Hussain, P Sung, ME Hoatlin, CG Mathew, M Takata, LH Thompson, GM Kupfer, and NJ Jones. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3. Oncogene. 2008 Jun 12;27(26):3641-52. PDF
  11. Sobeck, A., Stone, S., Hoatlin, M.E. DNA Structure-Induced Recruitment and Activation of the Fanconi Anemia Pathway Protein, FANCD2. Mol Cell Biol. 2007 Jun;27(12):4283-92. Epub 2007 Apr 9, Abstract Triggering FANCD2 without the replication machine running
  12. S. Stone, A. Sobeck, M. van Kogelenberg, B. de Graaf, H. Joenje, J. Christian, and M. E. Hoatlin. Identification, Developmental Expression, and Regulation of the Xenopus Ortholog of Human FANCG/XRCC9. Genes to Cells 2007 Jul;12(7):841–851. Abstract
  13. C. Ling, M. Ishiai, A. M. Ali, A. Medhurst, K. Neveling, R. Kalb, Z. Yan, Y. Xue1, A. Oostra, A. Auerbach, M. Hoatlin, Detlev Schindler, H. Joenje, J. de Winter, M. Takata, R. Meetei, and W. Wang. FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway EMBO J., 2007 Apr 18;26(8):2104-14; advance online publication 29 March 2007 Abstract.
  14. Sobeck, A., Stone, S. Costanzo, V., de Graaf, B., Reuter, T. de Winter, J., Wallisch, M., Akkari, Y., Olson, S., Wang, W., Joenje, H., Christian, J., Lupardus, P. L., Cimprich, K.A., Gautier, J., and Hoatlin, M. E. Fanconi Anemia Proteins are Required to Prevent Accumulation of Replication-Associated DNA Double Strand Breaks. Mol Cell Biol. 2006 Jan;26(2):425-37. Cover abstract PDF reprint This paper describes the first use of the Xenopus extract system for Fanconi proteins, including cloning of several of the Xenopus FA homologs
  15. Leveille F, Ferrer M, Medhurst AL, Laghmani el H, Rooimans MA, Bier P, Steltenpool J, Titus TA, Postlethwait JH, Hoatlin ME, Joenje H, de Winter JP. The nuclear accumulation of the Fanconi anemia protein FANCE depends on FANCC. DNA Repair (Amst). 2006 May 10;5(5):556-65. Epub 2006 Feb 28. abstract
  16. Meetei AR, Medhurst AL, Ling C, Xue Y, Singh TR, Bier P, Steltenpool J, Stone S, Dokal I, Mathew CG, Hoatlin M, Joenje H, de Winter JP, Wang W. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet. 2005, 37(9):958-63. abstract Highlighted by Faculty of 1000 as Must Read
  17. Yin J, Sobeck A, Xu C, Meetei AR, Hoatlin M, Li L, Wang W. BLAP75, an essential component of Bloom's syndrome protein complexes that maintain genome integrity. EMBO J. 2005. abstract
  18. Leveille F, Blom E, Medhurst AL, Bier P, Laghmani EH, Johnson M, Rooimans MA, Sobeck A, Waisfisz Q, Arwert F, ;Patel KJ, Hoatlin ME, Joenje H, De Winter JP. The Fanconi anemia gene product FANCF is a flexible adaptor protein. J Biol Chem. 2004, 279:39421-30. abstract
  19. Meetei, A. R., M. Levitus, Y. Xue, A. L. Medhurst, M. Zwaan, C. Ling, M. A. Rooimans, P. Bier, M. Hoatlin, G. Pals, J. P. de Winter, W. Wang, and H. Joenje. 2004. X-linked inheritance of Fanconi anemia complementation group B. Nat Genet 36:1219-24. abstract
  20. Levitus M, Rooimans MA, Steltenpool J, Cool NF, Oostra AB, Mathew CG, Hoatlin ME, Waisfisz Q, Arwert F, De Winter JP, Joenje H. Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood. 2003 abstract
  21. Meetei AR, De Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, Van De Vrugt HJ, Oostra AB, Yan Z, Ling C, Bishop CE, Hoatlin ME, Joenje H, Wang W. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet. 2003 Oct; 35(2):165-70 abstract Highlighted by Faculty of 1000 as Must Read
  22. Holzel M, Van Diest PJ, Bier P, Wallisch M, Hoatlin ME, Joenje H, De Winter JP. FANCD2 protein is expressed in proliferating cells of human tissues that are cancer-prone in Fanconi anaemia. J Pathol. 2003 Oct;201(2):198-203. abstract
  23. Reuter TY, Medhurst AL, Waisfisz Q, Zhi Y, Herterich S, Hoehn H, Gross HJ, Joenje H, Hoatlin ME, Mathew CG, Huber PA. Yeast two-hybrid screens imply involvement of fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport. Exp Cell Res. 2003 Oct 1;289(2):211-21. abstract
  24. Meetei AR, Sechi S, Wallisch M, Yang D, Young MK, Joenje H, Hoatlin ME, Wang W. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol Cell Biol. 2003 May;23(10):3417-26. abstract. This paper describes BRAFT. Daughters of BRAFT are (so far) FANCL, FANCB, BLAP75, FANCM, FAAP100.
  25. Ikeda H, Matsushita M, Waisfisz Q, Kinoshita A, Oostra AB, Nieuwint AW, De Winter JP, Hoatlin ME, Kawai Y, Sasaki MS, D'Andrea AD, Kawakami Y, Joenje H. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2. Cancer Res. 2003 May 15;63(10):2688-94. abstract
  26. Otsuki T, Young DB, Sasaki DT, Pando MP, Li J, Manning A, Hoekstra M, Hoatlin ME, Mercurio F, Liu JM. Fanconi anemia protein complex is a novel target of the IKK signalsome. J Cell Biochem. 2002;86(4):613-23. abstract
  27. Dai MS, Chevallier N, Stone S, Heinrich MC, McConnell M, Reuter T, Broxmeyer HE, Licht JD, Lu L, Hoatlin ME. The effects of the Fanconi anemia zinc finger (FAZF) on cell cycle, apoptosis, and proliferation are differentiation stage-specific. J Biol Chem. 2002 Jul 19;277(29):26327-34. abstract
  28. Pace P, Johnson M, Tan WM, Mosedale G, Sng C, Hoatlin M, de Winter J, Joenje H, Gergely F, Patel KJ. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J. 2002 Jul 1;21(13):3414-23. abstract
  29. van de Vrugt HJ, Koomen M, Berns MA, de Vries Y, Rooimans MA, van der Weel L, Blom E, de Groot J, Schepers RJ, Stone S, Hoatlin ME, Cheng NC, Joenje H, Arwert F. Characterization, expression and complex formation of the murine Fanconi anaemia gene product Fancg. Genes Cells. 2002 Mar;7(3):333-42. abstract
  30. Hoatlin M, Reuter T. Foci on fanconi. Trends Mol Med. 2001 Jun;7(6):237-9. abstract
  31. Xie Y, de Winter JP, Waisfisz Q, Nieuwint AW, Scheper RJ, Arwert F, Hoatlin ME, Ossenkoppele GJ, Schuurhuis GJ, Joenje H. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells. Br J Haematol. 2000 Dec;111(4):1057-64. abstract
  32. de Winter JP, van der Weel L, de Groot J, Stone S, Waisfisz Q, Arwert F, Scheper RJ, Kruyt FA, Hoatlin ME, Joenje H. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet. 2000 Nov 1;9(18):2665-74. abstract
  33. Heinrich MC, Silvey KV, Stone S, Zigler AJ, Griffith DJ, Montalto M, Chai L, Zhi Y, Hoatlin ME. Posttranscriptional cell cycle-dependent regulation of human FANCC expression. Blood. 2000 Jun 15;95(12):3970-7. abstract
  34. van de Vrugt HJ, Cheng NC, de Vries Y, Rooimans MA, de Groot J, Scheper RJ, Zhi Y, Hoatlin ME, Joenje H, Arwert F. Cloning and characterization of murine fanconi anemia group A gene: Fanca protein is expressed in lymphoid tissues, testis, and ovary. Mamm Genome. 2000 Apr;11(4):326-31. abstract
  35. de Winter JP, Rooimans MA, van Der Weel L, van Berkel CG, Alon N, Bosnoyan-Collins L, de Groot J, Zhi Y, Waisfisz Q, Pronk JC, Arwert F, Mathew CG, Scheper RJ, Hoatlin ME, Buchwald M, Joenje H. The Fanconi anaemia gene FANCF encodes a novel 42 kDA protein with homology to ROM. Nat Genet. 2000 Jan;24(1):15-6. abstract
  36. Hoatlin ME, Zhi Y, Ball H, Silvey K, Melnick A, Stone S, Arai S, Hawe N, Owen G, Zelent A, Licht JD. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF. Blood. 1999 Dec 1;94(11):3737-47. abstract Describes the cloning of FAZF
  37. Waisfisz Q, de Winter JP, Kruyt FA, de Groot J, van der Weel L, Dijkmans, LM, Zhi Y, Arwert F, Scheper RJ, Youssoufian H, Hoatlin ME, Joenje H. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10320-5. abstract
  38. Waisfisz Q, Morgan NV, Savino M, de Winter JP, van Berkel CG, Hoatlin ME, Ianzano L, Gibson RA, Arwert F, Savoia A, Mathew CG, Pronk JC, Joenje H. Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nat Genet. 1999 Aug;22(4):379-83. abstract
  39. Gomez-Lucia E, Zhi Y, Nabavi M, Zhang W, Kabat D, Hoatlin ME. An array of novel murine spleen focus-forming viruses that activate the erythropoietin receptor. J Virol. 1998 May;72(5):3742-50. abstract
  40. Hoatlin ME, Gomez-Lucia E, Lilly F, Beckstead JH, Kabat D. Origin and rapid evolution of a novel murine erythroleukemia virus of the spleen focus-forming virus family. J Virol. 1998 May;72(5):3602-9. abstract
  41. Hoatlin ME, Christianson TA, Keeble WW, Hammond AT, Zhi Y, Heinrich MC, Tower PA, Bagby GC Jr. The Fanconi anemia group C gene product is located in both the nucleus and cytoplasm of human cells. Blood. 1998 Feb 15;91(4):1418-25. abstract
  42. Heinrich MC, Hoatlin ME, Zigler AJ, Silvey KV, Bakke AC, Keeble WW, Zhi Y, Reifsteck CA, Grompe M, Brown MG, Magenis RE, Olson SB, Bagby GC. DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function. Blood. 1998 Jan 1;91(1):275-87. abstract
  43. Tower PA, Christianson TA, Peters ST, Ostroski ML, Hoatlin ME, Zigler AJ, Heinrich MC, Rathbun RK, Keeble W, Faulkner GR, Bagby GC Jr. Expression of the Fanconi anemia group C gene in hematopoietic cells is not influenced by oxidative stress, cross-linking agents, radiation, heat, or mitotic inhibitory factors. Exp Hematol. 1998 Jan;26(1):19-26. abstract
  44. Lu L, Ge Y, Li Z-H, Keeble W, Kabat D, Bagby G, Broxmeyer HE, and Hoatlin ME. Retroviral transfer of the recombinant human erythropoietin receptor gene into single hematopoietic stem/progenitor cells from human cord blood increases the number of erythropoietin dependent erythroid colonies. Blood (1996) 87:525-534.
  45. Tuachi T, Feng G-S, Shen R, Hoatlin ME, Kabat D, Bagby GC, Lu L, Broxmeyer H. Involvement of SH2 containing phophotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J. Biol Chem (1995) 270:5361-5365.
  46. Hoatlin ME, Ferro FE, Geib RW, Fox MT, Kozak SL, Kabat D. Deletions in one domain of the Friend virus-encoded glycoprotein overcome host-range restrictions for erythroleukemia. J Virol (1995) 69:856-863.
  47. Hoatlin, M.E., Frank Ferro, Jr., S.L. Kozak and D. Kabat. A Friend virus mutant encodes a small glycoprotein that causes erythroleukemia. (1994) J. Virol. 68:4053-4056
  48. Heinrich MC, Dooley DC, Freed A, Band L, Hoatlin ME, Keeble W, Peters ST, Silvey K, Ey FS, Kabat D, Maziarz RT, Bagby GC. Constitutive expression of steel factor gene by human stromal cells. Blood (1993) 82:771-783.
  49. Ferro, F.E. Jr., S.L. Kozak, M.E. Hoatlin and D. Kabat. Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein (gp55) encoded by Friend spleen focus-forming virus, (1993). J. Biol. Chem. 268: 5741-5747.
  50. Kozak, S.L., M.E. Hoatlin, F.E. Ferro Jr., M.K. Majumdar, R.W. Geib, M.T. Fox and D. Kabat. A Friend virus mutant that overcomes Fv-2rr host resistance encodes a small glycoprotein that dimerizes, is processed to cell surfaces, and specifically activates erythropoietin receptors, (1993). J. Virol 67:2611-2620.
  51. Hoatlin, M.E., S.L. Kozak, F. Lilly, A. Chakraborti, C.A. Kozak and D. Kabat. Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2 r resistance gene, (1990). Proc. Natl. Acad. Sci. USA, 87: 9985-9989.
  52. Hoatlin, M.E., O.M. Kew and M.E. Renz. Regions of Poliovirus protein VP1 produced in E. coli induce neutralizing antibodies, (1987). J. Virol., 61:1442-1447.
  53. Weddell, G.N., D.G. Yansura, D.J. Dowbenko, M.E. Hoatlin, M.J. Grubman, D.M. Moore and D.G. Kleid. Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type A, (1985) Proc. Natl. Acad. Sci., USA. vol. 82, pp. 2618-2622.

Back to Hoatlin Lab